Mirae Asset Global Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $133K | Buy |
3,652
+557
| +18% | +$20.3K | ﹤0.01% | 1098 |
|
2025
Q1 | $117K | Buy |
3,095
+18
| +0.6% | +$681 | ﹤0.01% | 1104 |
|
2024
Q4 | $134K | Sell |
3,077
-256
| -8% | -$11.1K | ﹤0.01% | 1109 |
|
2024
Q3 | $181K | Buy |
3,333
+851
| +34% | +$46.3K | ﹤0.01% | 1098 |
|
2024
Q2 | $103K | Sell |
2,482
-228,285
| -99% | -$9.46M | ﹤0.01% | 1137 |
|
2024
Q1 | $8.76M | Buy |
230,767
+122,412
| +113% | +$4.65M | 0.02% | 689 |
|
2023
Q4 | $5.18M | Sell |
108,355
-102,613
| -49% | -$4.91M | 0.01% | 883 |
|
2023
Q3 | $7.52M | Buy |
210,968
+18,845
| +10% | +$672K | 0.02% | 725 |
|
2023
Q2 | $8.87M | Sell |
192,123
-41,033
| -18% | -$1.89M | 0.02% | 702 |
|
2023
Q1 | $9.35M | Buy |
233,156
+8,479
| +4% | +$340K | 0.02% | 665 |
|
2022
Q4 | $10.4M | Buy |
224,677
+92,185
| +70% | +$4.27M | 0.03% | 584 |
|
2022
Q3 | $5.49M | Buy |
132,492
+4,333
| +3% | +$179K | 0.01% | 768 |
|
2022
Q2 | $7.65M | Sell |
128,159
-8,747
| -6% | -$522K | 0.02% | 698 |
|
2022
Q1 | $9.94M | Sell |
136,906
-23,821
| -15% | -$1.73M | 0.02% | 668 |
|
2021
Q4 | $13.5M | Buy |
160,727
+37,320
| +30% | +$3.14M | 0.03% | 582 |
|
2021
Q3 | $11.1M | Buy |
123,407
+21,012
| +21% | +$1.9M | 0.03% | 605 |
|
2021
Q2 | $9.76M | Buy |
102,395
+14,134
| +16% | +$1.35M | 0.03% | 642 |
|
2021
Q1 | $10M | Buy |
88,261
+33,663
| +62% | +$3.83M | 0.03% | 529 |
|
2020
Q4 | $7.56M | Buy |
54,598
+10,262
| +23% | +$1.42M | 0.03% | 568 |
|
2020
Q3 | $3.64M | Buy |
44,336
+12,691
| +40% | +$1.04M | 0.02% | 614 |
|
2020
Q2 | $2.48M | Buy |
31,645
+10,403
| +49% | +$814K | 0.01% | 657 |
|
2020
Q1 | $943K | Buy |
21,242
+2,248
| +12% | +$99.8K | 0.01% | 845 |
|
2019
Q4 | $811K | Buy |
18,994
+8,185
| +76% | +$349K | 0.01% | 1041 |
|
2019
Q3 | $463K | Buy |
10,809
+7,022
| +185% | +$301K | ﹤0.01% | 1186 |
|
2019
Q2 | $241K | Buy |
+3,787
| New | +$241K | ﹤0.01% | 1330 |
|